Design and construction of fusion genes hspX and tb10.4 from Mycobacterium tuberculosis in a cloning vector

References

• 1.
  Akhavan R, Meshkat Z, Jamehdar S. Comparing the frequency of mycobacterium tuberculosis with direct microscopy and culture methods. Jundishapur J Microbiol 2012; 6: 95-96. (Persian).
• 2.
  Gholoobi A, Masoudi-Kazemabad A, Meshkat M, Meshkat Z. Comparison of culture and PCR methods for diagnosis of mycobacterium tuberculosis in different clinical specimens. Jundishapur J Microbiol 2014; 7: e8939. (Persian).
• 3.
  Mohammadbeigi A, Dalirian S, Mokhtari M, Jadidi R. Delay in diagnosis and treatment of pulmonary tuberculosis and its association with some social and personal characteristics in Markazi Province (2008-2014). Koomesh 2015; 4: 966-973. (Persian).
• 4.
  Nabavinia MS, Meshkat Z, Derakhshan M, Khaje-Karamadini M. Construction of an expression vector containing Mtb72F of mycobacterium tuberculosis. Cell J (Yakhteh) 2012; 14: 61. (Persian).
• 5.
  Kaufmann SH. Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infect Dis 2011; 11: 633-640.
• 6.
  Baghani A, Youssefi M, Safdari H, Teimourpour R, Meshkat Z. Designing and construction pcdna3. 1 vector encoding Cfp10 gene of mycobacterium tuberculosis. Jundishapur J Microbiol 2015; 8. (Persian).##.
• 7.
  Gupta UD, Katoch VM, McMurray DN. Current status of TB vaccines. Vaccine 2007; 25: 3742-3751.
• 8.
  Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV. Efficacy of BCG vaccine in the prevention of tuberculosismeta-analysis of the published literature. Jama 1994; 271: 698-702.
• 9.
  Hoang T, Aagaard C, Dietrich J, Cassidy JP, Dolganov G, Schoolnik GK, et al. ESAT-6 (EsxA) and TB10. 4 (EsxH) based vaccines for pre-and post-exposure tuberculosis vaccination. PloS One 2013; 8: e80579.
• 10.
  Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC. Tuberculosis vaccine research: the impact of immunology. Curr Opin Immunol 2009; 21: 331-338.
• 11.
  Britton WJ, Palendira U. Improving vaccines against tuberculosis. Immunol Cell Biol 2003; 81: 34-45.
• 12.
  Wieczorek AE, Troudt JL, Knabenbauer P, Taylor J, Pavlicek RL, Karls R, et al. HspX vaccination and role in virulence in the guinea pig model of tuberculosis. Pathog Dis 2014; 71: 315-325.
• 13.
  Taylor JL, Wieczorek A, Keyser AR, Grover A, Flinkstrom R, Karls RK, et al. HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule. Immunol Cell Biol 2012; 90: 945-954.
• 14.
  Skjt RL, Oettinger T, Rosenkrands I, Ravn P, Brock I, Jacobsen S. Comparative evaluation of low-molecular-mass proteins from mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-Cell antigens. Infect Immun 2000; 68: 214-220.
• 15.
  Dietrich J, Aagaard C, Leah R, Olsen AW, Stryhn A, Doherty TM. Exchanging ESAT6 with TB10. 4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 2005; 174: 6332-6339.
• 16.
  Baghani A, Youssefi M, Safdari H, Teimourpour R, Meshkat Z. Designing and construction pcdna3. 1 vector encoding Cfp10 gene of mycobacterium tuberculosis. Jundishapur J Microbiol 2015; 8. (Persian).
• 17.
  Tajeddin E, Kargar M, Noroozi J, Ahmadi M, Kazempour M. Identification of mycobacterium tuberculosis beijing genotype using three different molecular methods. Koomesh 2009; 1: 7-14. (Persian).
• 18.
  D'Souza S, Denis O, Scorza T, Nzabintwali F, Verschueren H, Huygen K. CD4+ T cells contain Mycobacterium tuberculosis infection in the absence of CD8+ T cells in mice vaccinated with DNA encoding Ag85A. Eur J Immunol 2000; 30: 2455-2459.
• 19.
  Tanghe A, Lefvre P, Denis O, DSouza S, Braibant M, Lozes E, et al. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol 1999; 162: 1113-1119.
• 20.
  Radoevi K, Wieland CW, Rodriguez A, Weverling GJ, Mintardjo R, Gillissen G, et al. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 2007; 75: 4105-4115.
• 21.
  Wieczorek AE, Troudt JL, Knabenbauer P, Taylor J, Pavlicek RL, Karls R, et al. HspX vaccination and role in virulence in the guinea pig model of tuberculosis. Pathog Dis 2014; 71: 315-325.
• 22.
  Kamath A, Woodworth JS, Behar SM. Antigen-specific CD8+ T cells and the development of central memory during Mycobacterium tuberculosis infection. J Immunol 2006; 177: 6361-6369.
• 23.
  Sun R, Skeiky YA, Izzo A, Dheenadhayalan V, Imam Z, Penn E, et al. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Vaccine 2009; 27: 4412-4423.
• 24.
  Romano M, Aryan E, Korf H, Bruffaerts N, Franken C, Ottenhoff T. Potential of mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines. Microbes Infect 2012; 14: 86-95.
• 25.
  Soleimanpour S, Farsiani H, Mosavat A, Ghazvini K, Eydgahi MR, Sankian M, et al. APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice. Appl Microbiol Biotechnol 2015; 99: 10467-10480.
• 26.
  Xin Q, Niu H, Li Z, Zhang G, Hu L, Wang B, et al. Subunit vaccine consisting of multi-stage antigens has high protective efficacy against mycobacterium tuberculosis Infection in Mice. PloS One 2013; 8: e72745.
• 27.
  Marongiu L, Donini M, Toffali L, Zenaro E, Dusi S. ESAT-6 and HspX improve the effectiveness of BCG to induce human dendritic cells-dependent Th1 and NK cells activation. PloS One 2013; 8: e75684.
• 28.
  Niu H, Hu L, Li Q, Da Z, Wang B, Tang K, et al. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10. 4HspX. Vaccine 2011; 29: 9451-9458##.